Bomyntra

Denosumab is a medication used to treat conditions related to bone health. It works by inhibiting a protein involved in bone breakdown, helping to maintain bone density. This subcutaneous injection is commonly prescribed for osteoporosis and other bone-related disorders.

Denosumab is primarily used to treat osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis at high risk for fracture. It is also used to treat bone loss in patients receiving hormone ablation for prostate or breast cancer. Denosumab works by targeting a specific protein involved in bone breakdown, helping to maintain bone density and reduce the risk of fractures.

Common effects of Denosumab may include back pain, pain in extremities, high blood pressure, and bladder infection. Some patients may experience rash, eczema, or other skin reactions. It is important to discuss any persistent or severe side effects with a healthcare provider.

Denosumab should be used with caution in patients with a history of low calcium levels or dental issues. Regular monitoring of calcium levels and dental health is recommended. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Denosumab may interact with other medications, including those that affect the immune system or bone metabolism. It is important to discuss all current medications with a healthcare provider before starting Denosumab. Alcohol and certain supplements may also interact with Denosumab, so it is advisable to consult a healthcare professional for personalized advice.